发明名称 |
Swallowable capsule and method for stimulating incretin production within the intestinal tract |
摘要 |
Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract. The capsule can include two or more electrodes for providing electrical stimulation to L-cells, a power source for powering one or more components of the capsule, a sensor for sensing the location of the capsule in the intestinal tract; a controller and a waveform generator for generating the electrical signals emitted by the electrodes to stimulate the L-cells to secrete incretins such as GLP-1 to stimulate insulin production for glucose regulation of diabetic conditions. |
申请公布号 |
US8781591(B2) |
申请公布日期 |
2014.07.15 |
申请号 |
US201414179215 |
申请日期 |
2014.02.12 |
申请人 |
Incube Labs, LLC |
发明人 |
Imran Mir A.;Hashim Mir;Arnsdorf Emily |
分类号 |
A61N1/06;A61N1/05;A61N1/36 |
主分类号 |
A61N1/06 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for stimulating L-cells in an intestinal track of a patient to secrete a polypeptide, the method comprising:
ingesting a swallowable device configured to travel through the intestinal tract and electrically stimulate the L-cells at any location in the intestinal tract; delivering an electrical signal from the device to an intestinal wall proximate the device, wherein the signal includes a waveform configured to electrically stimulate the L-cells in the intestinal tract to secrete the polypeptide without substantially causing a peristaltic contraction. |
地址 |
San Jose CA US |